- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02655835
Internet Mindfulness Meditation Intervention (IMMI)
Phase 1 will follow 40 subjects and hopes to address whether or not IMMI can increase meditation practice as compared to another meditation program. The study will last six weeks for both the IMMI group (20 subjects) and the Access group (20 subjects). Access groups will receive learning materials and guided meditations, but the implementation will be self-paced. Participants in the IMMI group will receive weekly learning sessions and be required to practice meditation every day. IMMI group participants will also receive a weekly reminder call from a member of the study staff and have access to technical support in the event of trouble with the online program. All subjects will complete online self-report questionnaires that measure quality of life, self-efficacy, mood, sleep, mindfulness, and perceived stress at baseline and at the end of the six-week intervention. Subjects will also be given a questionnaire at the end of the study gauging their satisfaction with the mindfulness program they participated in.
Phase 2 will follow 80 subjects and hopes to address whether or not IMMI is acceptable to participants and demographic information about IMMI users. The study will be the same as noted above, but all subjects will be entered in the IMMI program.
Differences in recruitment rates, drop out, and patient satisfaction between the IMMI and Access groups will be analyzed. IMMI's ability to change meditation behavior (i.e. increasing time or frequency of meditation sessions), and improve quality of life will be examined as well.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 - 80 years old
- Access to Computer and Internet
- Can hear and understand instructions
- Willing to accept randomization scheme and agrees to follow the study protocol
Exclusion Criteria:
- Significant acute medical illness that would decrease likelihood of study completion (self-report)
- Significant, untreated depression, as assessed by CESD-5 >20 during screening
- Current daily meditation practice (≥ 5 min/day daily for at least 30 days in the last 6 months. Past practice not exclusionary but will be recorded)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Internet Mindfulness Meditation Intervention
Six-week internet mindfulness meditation training program including handouts and daily guided meditations
|
|
|
Experimental: Access
Written information handouts on mindfulness meditation and access to guided daily meditations
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Enrollment rate
Time Frame: Week 0 - Screening
|
Number of participants who are eligible and enroll in the study
|
Week 0 - Screening
|
|
Participant satisfaction
Time Frame: Week 8 - Endpoint assessment
|
Client Satisfaction Questionnaire
|
Week 8 - Endpoint assessment
|
|
Number of internet mindfulness meditation training sessions completed
Time Frame: Week 8 - Endpoint Assessment (after intervention is complete)
|
There are a total of 6 internet training sessions, and participants are instructed to complete one per week (where Week 0 is screening, Week 1 is Baseline Assessment, Week 2 is Training 1, Week 3 is Training 2, Week 4 is Training 3, Week 5 is Training 4, Week 6 is Training 5, and Week 7 is Training 6) .
At the time of the endpoint assessment (Week 8), the number of completed training sessions is tabulated.
|
Week 8 - Endpoint Assessment (after intervention is complete)
|
|
Completion Rate
Time Frame: Week 8 - Endpoint assessment
|
Number of participants who complete the endpoint assessment.
|
Week 8 - Endpoint assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life SF-36
Time Frame: Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
Measured with Short-Form Health Survey (SF-36) self-report measure
|
Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
|
Self-efficacy
Time Frame: Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
Measured with General Perceived Self Efficacy (GPSE) self-report questionnaire
|
Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
|
Mood
Time Frame: Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
Measured with Center for Epidemiological Studies Depression Scale (CESD) self-report questionnaire
|
Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
|
Sleep
Time Frame: Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
Measured with Pittsburgh Sleep Quality Index (PSQI) self-report questionnaire
|
Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
|
Mindfulness
Time Frame: Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
Measured with Five Factor Mindfulness Questionnaire (FFMQ)
|
Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
|
Perceived Stress
Time Frame: Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
Measured with perceived stress scale (PSS)
|
Week 1 - Baseline assessment & Week 8 - Endpoint assessment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Barry S Oken, MD, MS, Oregon Health and Science University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 10939
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustEnrolling by invitationOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States
-
Dana-Farber Cancer InstituteCompletedStress | Post Traumatic Stress Disorder | Work Related StressUnited States
Clinical Trials on Internet Mindfulness Meditation
-
Oregon Health and Science UniversityCompleted
-
University of California, San FranciscoAmerican Society of HematologyCompletedChronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Myeloproliferative NeoplasmUnited States
-
University Hospital, AngersWithdrawnLateral Sclerosis Amyotrophy | Mindfulness Meditation
-
University of Illinois at Urbana-ChampaignNorthwestern University Feinberg School of Medicine; Southern Illinois University and other collaboratorsNot yet recruitingPain, Postoperative | Depression, Unipolar
-
Equa HealthNational Institute of Mental Health (NIMH); Worcester Polytechnic InstituteRecruitingPsychological Distress | Mindfulness Skills | Usability SatisfactionUnited States
-
Barbara L. Fredrickson, PhDNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Universiti Tunku Abdul RahmanRecruiting
-
Icahn School of Medicine at Mount SinaiTerminatedPain, Postoperative | Spine Surgery | MeditationUnited States
-
York UniversityCompletedChronic Pain | Depression, AnxietyCanada
-
Jordan University of Science and TechnologyCompletedChronic Kidney Diseases | Hemodialysis ComplicationJordan